Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.45NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GP.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
V.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.149NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.413NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.107NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.10 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.41 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AS.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.142NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.166NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.11 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.34.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.60NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
W.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.250NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.63NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.130NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.469NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.311NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.93NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.104NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.225NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-14372.8South Korea
B.1.1.309NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.105NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.307NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.171NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used